(PLAB) Photronics - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7194051022
Stock: Photomasks, Semiconductors, Displays, Components
Total Rating 59
Risk 95
Buy Signal 0.68
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 58.1% |
| Relative Tail Risk | -12.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.96 |
| Alpha | 38.90 |
| Character TTM | |
|---|---|
| Beta | 1.731 |
| Beta Downside | 1.354 |
| Drawdowns 3y | |
|---|---|
| Max DD | 50.62% |
| CAGR/Max DD | 0.53 |
Description: PLAB Photronics January 19, 2026
Photronics, Inc. (NASDAQ:PLAB) manufactures and sells photomasks-critical lithography tools that transfer circuit designs onto semiconductor wafers and flat-panel-display substrates-for customers worldwide, including integrated-circuit designers, foundries, and display manufacturers. The firm operates production facilities across the United States, Taiwan, China, Korea, and Europe, and also offers related electrical and optical components.
Key metrics that shape PLAB’s outlook include FY 2023 revenue of roughly $330 million with a gross margin near 38 %, and a customer concentration where the top three accounts account for about 45 % of sales-highlighting exposure to the cyclical demand of leading-edge fabs. The company’s growth is tightly linked to semiconductor-industry drivers such as the ramp-up of 3 nm and EUV-based nodes, which increase photomask complexity and pricing, and to the broader macro trend of expanding fab capacity in Asia (e.g., TSMC’s 2024 capacity additions). A material risk is the firm’s reliance on a limited number of high-volume customers; a slowdown in advanced-node spending could compress margins.
For a deeper quantitative view, explore the PLAB analysis page on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 136.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -4.32 > 1.0 |
| NWC/Revenue: 85.27% < 20% (prev 86.19%; Δ -0.93% < -1%) |
| CFO/TA 0.14 > 3% & CFO 247.8m > Net Income 136.4m |
| Net Debt (-492.2m) to EBITDA (299.4m): -1.64 < 3 |
| Current Ratio: 5.37 > 1.5 & < 3 |
| Outstanding Shares: last quarter (58.0m) vs 12m ago -7.07% < -2% |
| Gross Margin: 35.30% > 18% (prev 0.36%; Δ 3494 % > 0.5%) |
| Asset Turnover: 48.30% > 50% (prev 50.64%; Δ -2.34% > 0%) |
| Interest Coverage Ratio: 2112 > 6 (EBITDA TTM 299.4m / Interest Expense TTM 105.0k) |
Altman Z'' 8.79
| A: 0.40 (Total Current Assets 890.1m - Total Current Liabilities 165.9m) / Total Assets 1.80b |
| B: 0.43 (Retained Earnings 772.2m / Total Assets 1.80b) |
| C: 0.13 (EBIT TTM 221.8m / Avg Total Assets 1.76b) |
| D: 3.73 (Book Value of Equity 772.2m / Total Liabilities 207.2m) |
| Altman-Z'' Score: 8.79 = AAA |
Beneish M -2.78
| DSRI: 0.93 (Receivables 195.9m/215.0m, Revenue 849.3m/866.9m) |
| GMI: 1.03 (GM 35.30% / 36.44%) |
| AQI: 1.59 (AQ_t 0.03 / AQ_t-1 0.02) |
| SGI: 0.98 (Revenue 849.3m / 866.9m) |
| TATA: -0.06 (NI 136.4m - CFO 247.8m) / TA 1.80b) |
| Beneish M-Score: -2.78 (Cap -4..+1) = A |
What is the price of PLAB shares?
As of February 07, 2026, the stock is trading at USD 37.24 with a total of 1,098,821 shares traded.
Over the past week, the price has changed by +7.72%, over one month by +5.80%, over three months by +64.20% and over the past year by +62.69%.
Over the past week, the price has changed by +7.72%, over one month by +5.80%, over three months by +64.20% and over the past year by +62.69%.
Is PLAB a buy, sell or hold?
Photronics has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy PLAB.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PLAB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 42 | 12.8% |
| Analysts Target Price | 42 | 12.8% |
| ValueRay Target Price | 46.4 | 24.6% |
PLAB Fundamental Data Overview February 01, 2026
P/E Trailing = 15.5022
P/S = 2.4042
P/B = 1.7756
P/EG = 4.27
Revenue TTM = 849.3m USD
EBIT TTM = 221.8m USD
EBITDA TTM = 299.4m USD
Long Term Debt = 5.96m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 11.0k USD (from shortTermDebt, last quarter)
Debt = 24.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -492.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.45b USD (2.04b + Debt 24.0k - CCE 588.2m)
Interest Coverage Ratio = 2112 (Ebit TTM 221.8m / Interest Expense TTM 105.0k)
EV/FCF = 24.40x (Enterprise Value 1.45b / FCF TTM 59.6m)
FCF Yield = 4.10% (FCF TTM 59.6m / Enterprise Value 1.45b)
FCF Margin = 7.01% (FCF TTM 59.6m / Revenue TTM 849.3m)
Net Margin = 16.06% (Net Income TTM 136.4m / Revenue TTM 849.3m)
Gross Margin = 35.30% ((Revenue TTM 849.3m - Cost of Revenue TTM 549.5m) / Revenue TTM)
Gross Margin QoQ = 35.01% (prev 33.68%)
Tobins Q-Ratio = 0.81 (Enterprise Value 1.45b / Total Assets 1.80b)
Interest Expense / Debt = 12.50% (Interest Expense 3000 / Debt 24.0k)
Taxrate = 14.23% (31.6m / 221.8m)
NOPAT = 190.2m (EBIT 221.8m * (1 - 14.23%))
Current Ratio = 5.37 (Total Current Assets 890.1m / Total Current Liabilities 165.9m)
Debt / Equity = 0.00 (Debt 24.0k / totalStockholderEquity, last quarter 1.60b)
Debt / EBITDA = -1.64 (Net Debt -492.2m / EBITDA 299.4m)
Debt / FCF = -8.26 (Net Debt -492.2m / FCF TTM 59.6m)
Total Stockholder Equity = 1.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.76% (Net Income 136.4m / Total Assets 1.80b)
RoE = 11.02% (Net Income TTM 136.4m / Total Stockholder Equity 1.24b)
RoCE = 17.83% (EBIT 221.8m / Capital Employed (Equity 1.24b + L.T.Debt 5.96m))
RoIC = 16.81% (NOPAT 190.2m / Invested Capital 1.13b)
WACC = 12.29% (E(2.04b)/V(2.04b) * Re(12.29%) + D(24.0k)/V(2.04b) * Rd(12.50%) * (1-Tc(0.14)))
Discount Rate = 12.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.35%
[DCF Debug] Terminal Value 64.70% ; FCFF base≈87.9m ; Y1≈90.8m ; Y5≈102.6m
Fair Price DCF = 24.81 (EV 973.4m - Net Debt -492.2m = Equity 1.47b / Shares 59.1m; r=12.29% [WACC]; 5y FCF grow 3.36% → 2.90% )
EPS Correlation: -26.82 | EPS CAGR: -46.73% | SUE: -4.0 | # QB: 0
Revenue Correlation: 26.79 | Revenue CAGR: 3.48% | SUE: 1.40 | # QB: 1
EPS next Quarter (2026-04-30): EPS=0.50 | Chg30d=+0.030 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-10-31): EPS=2.06 | Chg30d=+0.050 | Revisions Net=+1 | Growth EPS=+2.5% | Growth Revenue=+4.2%
EPS next Year (2027-10-31): EPS=2.22 | Chg30d=+0.090 | Revisions Net=+0 | Growth EPS=+7.8% | Growth Revenue=+7.0%
P/S = 2.4042
P/B = 1.7756
P/EG = 4.27
Revenue TTM = 849.3m USD
EBIT TTM = 221.8m USD
EBITDA TTM = 299.4m USD
Long Term Debt = 5.96m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 11.0k USD (from shortTermDebt, last quarter)
Debt = 24.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -492.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.45b USD (2.04b + Debt 24.0k - CCE 588.2m)
Interest Coverage Ratio = 2112 (Ebit TTM 221.8m / Interest Expense TTM 105.0k)
EV/FCF = 24.40x (Enterprise Value 1.45b / FCF TTM 59.6m)
FCF Yield = 4.10% (FCF TTM 59.6m / Enterprise Value 1.45b)
FCF Margin = 7.01% (FCF TTM 59.6m / Revenue TTM 849.3m)
Net Margin = 16.06% (Net Income TTM 136.4m / Revenue TTM 849.3m)
Gross Margin = 35.30% ((Revenue TTM 849.3m - Cost of Revenue TTM 549.5m) / Revenue TTM)
Gross Margin QoQ = 35.01% (prev 33.68%)
Tobins Q-Ratio = 0.81 (Enterprise Value 1.45b / Total Assets 1.80b)
Interest Expense / Debt = 12.50% (Interest Expense 3000 / Debt 24.0k)
Taxrate = 14.23% (31.6m / 221.8m)
NOPAT = 190.2m (EBIT 221.8m * (1 - 14.23%))
Current Ratio = 5.37 (Total Current Assets 890.1m / Total Current Liabilities 165.9m)
Debt / Equity = 0.00 (Debt 24.0k / totalStockholderEquity, last quarter 1.60b)
Debt / EBITDA = -1.64 (Net Debt -492.2m / EBITDA 299.4m)
Debt / FCF = -8.26 (Net Debt -492.2m / FCF TTM 59.6m)
Total Stockholder Equity = 1.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.76% (Net Income 136.4m / Total Assets 1.80b)
RoE = 11.02% (Net Income TTM 136.4m / Total Stockholder Equity 1.24b)
RoCE = 17.83% (EBIT 221.8m / Capital Employed (Equity 1.24b + L.T.Debt 5.96m))
RoIC = 16.81% (NOPAT 190.2m / Invested Capital 1.13b)
WACC = 12.29% (E(2.04b)/V(2.04b) * Re(12.29%) + D(24.0k)/V(2.04b) * Rd(12.50%) * (1-Tc(0.14)))
Discount Rate = 12.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.35%
[DCF Debug] Terminal Value 64.70% ; FCFF base≈87.9m ; Y1≈90.8m ; Y5≈102.6m
Fair Price DCF = 24.81 (EV 973.4m - Net Debt -492.2m = Equity 1.47b / Shares 59.1m; r=12.29% [WACC]; 5y FCF grow 3.36% → 2.90% )
EPS Correlation: -26.82 | EPS CAGR: -46.73% | SUE: -4.0 | # QB: 0
Revenue Correlation: 26.79 | Revenue CAGR: 3.48% | SUE: 1.40 | # QB: 1
EPS next Quarter (2026-04-30): EPS=0.50 | Chg30d=+0.030 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-10-31): EPS=2.06 | Chg30d=+0.050 | Revisions Net=+1 | Growth EPS=+2.5% | Growth Revenue=+4.2%
EPS next Year (2027-10-31): EPS=2.22 | Chg30d=+0.090 | Revisions Net=+0 | Growth EPS=+7.8% | Growth Revenue=+7.0%